“Biotech IPOs have…helped drug developers raise over $5 billion so far this year, and it doesn’t look like it will slow down,” observes the author of today’s article. For this reason, he recommends “keeping an eye on most of the most recent biotech IPOs” – and he highlights two of the most recent biotech IPOs worth keeping an eye on. For more, CLICK HERE.
The Most Recent Biotech IPOs To Keep An Eye On
- by Alex Clarke
